预防性吲哚美辛与延迟保守管理对极早产儿动脉导管未闭的疗效比较
这项前瞻性双队列对照研究纳入胎龄≤276/7周的极早产儿397例,比较预防性吲哚美辛(PINDO)与延迟保守管理对中大型动脉导管未闭(PDA)的发病率影响。结果显示PINDO队列第7天中大型PDA发生率显著更低(10% vs 67%),且支气管肺发育不良(BPD)及BPD或死亡风险显著降低,但调整第7天PDA存在后BPD获益不再显著,提示效应由PDA关闭介导。
要点
- 预防性吲哚美辛较延迟保守管理显著降低第7天中大型PDA发生率(10% vs 67%)。
- PINDO队列BPD风险比0.68(95%CI 0.46-0.89),BPD或死亡风险比0.78(95%CI 0.62-0.95)。
- 调整第7天中大型PDA后BPD获益不再显著,提示效应由PDA关闭介导。
核心结论
- 预防性吲哚美辛较延迟保守管理降低BPD及BPD或死亡风险,该效应由PDA关闭介导。
研究设计与样本
- 前瞻性双队列对照研究,纳入胎龄≤276/7周极早产儿397例。
- 2005年1月至2011年4月所有患儿接受预防性吲哚美辛(n=247)。
- 2011年5月至2016年8月无一患儿在生后至少8天内使用吲哚美辛(保守队列,n=150)。
- 第7天及之后按计划间隔行超声心动图直至PDA变小或关闭,由单一新生儿科医生前瞻性收集所有数据。
主要发现
- 第7天中大型PDA发生率PINDO队列为10%、保守队列为67%,中大型PDA暴露时间中位数分别为2天和14天。
- 两队列结扎率均低(PINDO=14%,保守=5%)。
- 多变量分析中PINDO患儿BPD风险比0.68(95%CI 0.46-0.89)、BPD或死亡风险比0.78(95%CI 0.62-0.95),均显著低于保守组。
- 两队列在死亡、3级和4级脑室内出血、坏死性小肠结肠炎、需治疗的早产儿视网膜病变方面无差异。
- 调整第7天中大型PDA存在后,PINDO对BPD及BPD或死亡的影响不再显著;PINDO的显著效应与是否行结扎无关。
临床怎么用
- 对极早产儿中大型PDA,预防性吲哚美辛可降低第7天PDA发生率并可能减少BPD,但需权衡利弊。
- 临床决策时应考虑PDA关闭是BPD获益的关键中介,延迟保守管理亦为可选策略。
局限性
- 研究为双队列对照设计而非随机对照试验,可能存在时代偏倚。
- 调整第7天中大型PDA后BPD获益不再显著,提示效应由PDA关闭介导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether prophylactic indomethacin (PINDO) has more or less morbidity than delayed conservative management of the moderate-to-large patent ductus arteriosus (PDA). STUDY DESIGN: We performed a prospective double cohort controlled study of infants delivered at ≤276/7 weeks gestation (n = 397). From January 2005 through April 2011, all infants were treated with PINDO (n = 247). From May 2011 through August 2016, no infant was treated with indomethacin until at least 8 postnatal days (conservative epoch, n = 150). Echocardiograms were performed on day 7 and at planned intervals until the PDA was small or closed. A single neonatologist prospectively collected all data. RESULTS: The incidence of moderate-to-large PDA on day 7 and duration of exposure to moderate-to-large PDA were significantly less in the PINDO epoch (incidence = 10%, median = 2 days) than the conservative epoch (incidence = 67%, median = 14 days). Ligation rates were low in both epochs (PINDO = 14%, conservative = 5%). In multivariate analyses, PINDO infants had a significantly lower incidence of bronchopulmonary dysplasia (BPD) (risk ratio = 0.68, CI: 0.46-0.89) and BPD or death (risk ratio= 0.78, CI: 0.62-0.95) than conservative infants. There were no differences between the epochs in death, intraventricular hemorrhage grades 3 and 4, necrotizing enterocolitis, or retinopathy of prematurity receiving treatment. The effects of PINDO on BPD and BPD or death were no longer significant when analyses were adjusted for presence of a moderate-to-large PDA on day 7. The significant effects of PINDO were independent of whether or not a ligation was performed. CONCLUSIONS: PINDO decreases BPD and BPD or death compared with delayed conservative PDA management. These effects are mediated by closure of the PDA.
引用
- Liebowitz M, Clyman RI. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes. J Pediatr. 2017. PMID: 28396025. doi:10.1016/j.jpeds.2017.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。